Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice

Endocrinology

Volumn 140, Issue 12, 1999, Pages 5719-5728

  Miyakoshi, Naohisa ^a   Richman, Charmaine ^a   Qin, Xuezhong ^a,b   Baylink, David J ^a,b   Mohan, Subburaman ^a,b  

^a Jerry L Pettis Memorial VA Medical Center   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; OSTEOCALCIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 4;

ANIMAL EXPERIMENT; ARTICLE; DOSE RESPONSE; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEPTOR AFFINITY; RECEPTOR BINDING;

EID: 0033304753     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.12.7175     Document Type: Article

References (45)

1. Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats
2. Growth factors to stimulate bone formation
3. Regulatory effects of insulin-like growth factors I and II on bone collagen synthesis in rat calvarial cultures
4. Short-term effects of recombinant human insulin-like growth factor I on bone turnover in normal women
5. Role of insulin-like growth factors in embryonic and postnatal growth
6. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting
7. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf-1)
8. IGF-I is required for normal embryonic growth in mice
9. Inactivation of the IGF-I gene in mice results in perinatal lethality
10. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
11. Insulin-like growth factor I gene deletion causing intrauterine growth retardation and severe short stature
12. In vivo actions of insulin-like growth factor-I (IGF-I) on bone formation and resorption in rats
13. Insulin-like growth factor system components and the coupling of bone formation to resorption
14. Growth hormone and bone
15. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
16. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
17. Insulin-like growth factor binding protein-4 inhibits both basal and IGF-mediated chick pelvic cartilage growth in vitro
18. Structure-function analysis of the human insulin-like growth factor binding protein-4
19. Recombinant synthesis of insulin-like growth factor-binding protein-4 (IGFBP-4): Development, validation, and application of a radioimmunoassay for IGFBP-4 in human serum and other biological fluids
20. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action
21. Stimulation of bone formation in vivo by insulin-like growth factor-II in rats
22. In vivo stimulation of bone formation by transforming growth factor-β
23. In vivo effects of human recombinant transforming growth factor β on bone turnover in normal mice
24. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats
25. 18 Sep-Pak separation
26. Development of valid methods to measure insulin-like growth factors-I and -II in bone cell-conditioned medium
27. Novel genetic model of peak bone density: A polygenic trait program
28. Specific activity of skeletal alkaline phosphatase in human osteoblast-line cells regulated by phosphate, phosphate esters, and phosphate analogs and release of alkaline phosphatase activity inversely regulated by calcium
29. Autocrine regulators of MC3T3-E1 cell proliferation
30. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats
31. IGF-I and pamidronate increase bone mineral density in ovariectomized adult rats
32. Effect of locally infused IGF-I on femoral gene expression and bone turnover activity in old rats
33. Insulin-like growth factors and their binding proteins: Biological actions
34. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia
35. Characterization of the affinities of insulin-like growth factor (IGF)- binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs
36. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites
37. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss with aging
38. Pharmacokinetics and bioavailability of rhIGF-I/IGFBP-3 in the rat and monkey
39. The insulin-like growth factor-binding protein-4 (IGFBP-4)-IGFBP-4 protease system in normal human osteoblast-like cells: Regulation by transforming growth factor-β
40. Insulin-like growth factor-II enhancement of human fibroblast growth via a nonreceptor-mediated mechanism
41. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases
42. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): Evidence for a suppressive action of free rather than bound IGF-I
43. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)- deficient adults and increase with GH replacement therapy
44. Effects of chronic renal failure and growth hormone on serum levels of insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 in children: A report of the Southwest Pediatric Nephrology Study Group